Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Tries To Climb Back Up From ICD Market Share Spill

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific is banking on intense communication with physicians and new product launches to eventually pull its ICD business back to its pre-sales-suspension standing, but the firm acknowledges that it will be playing catch-up for the foreseeable future

You may also be interested in...



St. Jude Warns Of Battery-Depletion Issues With Some ICDs

St. Jude Medical has issued a warning about premature battery depletion issues in some ICDs, but says it has already fixed the problem. Analysts say it is not likely to have any impact on Abbott’s plans to acquire St. Jude by the end of 2016.

Medtronic Q1 Revenues Fall 4% On Decreased Hospital Utilization

Medtronic is blaming a 4% decline in corporate first quarter sales on worsening hospital utilization rates in the U.S. The businesses most affected were Cardiac Rhythm Disease Management and Spine, CEO Bill Hawkins reported during an Aug. 24 earnings call

Medtronic Q1 Revenues Fall 4% On Decreased Hospital Utilization

Medtronic is blaming a 4% decline in corporate first quarter sales on worsening hospital utilization rates in the U.S. The businesses most affected were Cardiac Rhythm Disease Management and Spine, CEO Bill Hawkins reported during an Aug. 24 earnings call

Related Content

Topics

UsernamePublicRestriction

Register

MT028807

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel